De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling
Human Cell · 2023
DOI: 10.1007/s13577-023-00975-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2023. Verfasst von Hiroyuki Uematsu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29, Shimoadachi-cho, Sakyo-ku, Kyoto,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Organoids, Receptors, Notch, Signal Transduction. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Kyoto University Foundation.
Abstract (Originalsprache)
Estrogen receptor (ER) expression in breast cancer can change during progression and the treatment, but the mechanism has not been well studied. In this study, we successfully prepared organoids from samples obtained from 33 luminal-type breast cancer patients and studied their ER expression. The expression status was well maintained in primary organoids, whereas it decreased after passaging in most of the cases. In fact, the studied organoid lines were classified into those that retained a high level of ER expression (9%), those that completely lost it (9%), and those that repressed it to varying degrees (82%). In some cases, the ER expression was suddenly and drastically decreased after passaging. Marker protein immunohistochemistry revealed that after passaging, the differentiation status shifted from a luminal- to a basal-like status. Differentially expressed genes suggested the activation of NOTCH signaling in the passaged organoids, wherein a NOTCH inhibitor was able to substantially rescue the decreased ER expression and alter the differentiation status. Our findings suggest that the differentiation status of luminal-type cancer cells is quite flexible, and that by inhibiting the NOTCH signaling we can preserve the differentiation status of luminal-type breast cancer organoids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29, Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8304, Japan.
- KBBM Inc, 46-29, Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8304, Japan.
- Division of Health Sciences, Department of Molecular Biology and Clinical Investigation, Graduate School of Medicine, Osaka University, Osaka, Japan.
- Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
- Department of Breast Surgery, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
- Department of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29, Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8304, Japan. masa_inoue@kuhp.kyoto-u.ac.jp.
Förderung
- Kyoto University Foundation
Zitieren
APA
Uematsu, H., Saito, C., Kondo, J., Onuma, K., Coppo, R., Mori, Y., Muto, M., Kikawa, Y., Tada, M., Sugie, T., & Inoue, M. (2023). De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling. Human Cell. https://doi.org/10.1007/s13577-023-00975-7
Vancouver
Uematsu H, Saito C, Kondo J, Onuma K, Coppo R, Mori Y, et al. De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling. Human Cell. 2023. doi:10.1007/s13577-023-00975-7
BibTeX
@article{Uematsu2023,
author = {Uematsu, Hiroyuki and Saito, Chieko and Kondo, Jumpei and Onuma, Kunishige and Coppo, Roberto and Mori, Yukiko and Muto, Manabu and Kikawa, Yuichiro and Tada, Manami and Sugie, Tomoharu and Inoue, Masahiro},
title = {De-differentiation in cultures of organoids from luminal-type breast cancer is restored by inhibition of NOTCH signaling},
journal = {Human Cell},
year = {2023},
doi = {10.1007/s13577-023-00975-7}
}
EUVIMED